Literature DB >> 31359245

Thyroid hormone metabolites and analogues.

Rosalba Senese1, Federica Cioffi2, Giuseppe Petito1, Fernando Goglia2, Antonia Lanni3.   

Abstract

Several metabolic products that derive from L-thyroxine (T4) and 3,3'5-L-triiodothyronine (T3), the main thyroid hormones secreted by the thyroid gland, possess biologic activities. Among these metabolites or derivatives showing physiological actions some have received greater attention: diiodothyronines, iodothyronamines, acetic acid analogues. It is known that increased thyroid hormone (T3 and T4) levels can improve serum lipid profiles and reduce body fat. These positive effects are, however, counterbalanced by adverse effects on the heart, muscle and bone, limiting their use. In addition to the naturally occurring metabolites, thyroid hormone analogues have been developed that either have selective effects on specific tissues or bind selectively to thyroid hormone receptor (TR) isoform. Among these GC-1, KB141, KB2115, and DITPA were deeply investigated and displayed promising therapeutic results in the potential treatment of conditions such as dyslipidemias and obesity. In this review, we summarize the current knowledge of metabolites and analogues of T4 and T3 with reference to their possible clinical application in the treatment of human diseases.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31359245     DOI: 10.1007/s12020-019-02025-5

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  79 in total

1.  Evidence for extrathyroidal formation of 3-iodothyronamine in humans as provided by a novel monoclonal antibody-based chemiluminescent serum immunoassay.

Authors:  Carolin S Hoefig; Josef Köhrle; Georg Brabant; Kashinath Dixit; Beng Yap; Christian J Strasburger; Zida Wu
Journal:  J Clin Endocrinol Metab       Date:  2011-04-13       Impact factor: 5.958

2.  Pathological Interactions Between Mutant Thyroid Hormone Receptors and Corepressors and Their Modulation by a Thyroid Hormone Analogue with Therapeutic Potential.

Authors:  Déborah Harrus; Hélène Déméné; Edwin Vasquez; Abdelhay Boulahtouf; Pierre Germain; Ana Carolina Figueira; Martin L Privalsky; William Bourguet; Albane le Maire
Journal:  Thyroid       Date:  2018-10-16       Impact factor: 6.568

3.  3,5-Diiodo-L-thyronine modulates the expression of genes of lipid metabolism in a rat model of fatty liver.

Authors:  Elena Grasselli; Adriana Voci; Ilaria Demori; Laura Canesi; Rita De Matteis; Fernando Goglia; Antonia Lanni; Gabriella Gallo; Laura Vergani
Journal:  J Endocrinol       Date:  2011-11-22       Impact factor: 4.286

4.  Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-β agonist.

Authors:  Rebecca Taub; Edward Chiang; Malorie Chabot-Blanchet; Martha J Kelly; Richard A Reeves; Marie-Claude Guertin; Jean-Claude Tardif
Journal:  Atherosclerosis       Date:  2013-08-21       Impact factor: 5.162

5.  Both 3,5-diiodo-L-thyronine (T2) and T3 modulate glucose-induced insulin secretion.

Authors:  P Fallahi; S M Ferrari; E Santini; S Camastra; G Frenzilli; M Puccini; F Goglia; A Lanni; P Marchetti; A Antonelli
Journal:  J Biol Regul Homeost Agents       Date:  2017 Apr-Jun       Impact factor: 1.711

6.  The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity.

Authors:  S U Trost; E Swanson; B Gloss; D B Wang-Iverson; H Zhang; T Volodarsky; G J Grover; J D Baxter; G Chiellini; T S Scanlan; W H Dillmann
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

7.  In vitro binding of triiodothyronine to rat liver mitochondria.

Authors:  F Goglia; J Torresani; P Bugli; A Barletta; G Liverini
Journal:  Pflugers Arch       Date:  1981-05       Impact factor: 3.657

8.  Reverse T3 interacts with αvβ3 integrin receptor and restores enzyme activities in the hippocampus of hypothyroid developing rats: Insight on signaling mechanisms.

Authors:  Juliana Tonietto Domingues; Daiane Cattani; Patricia Acordi Cesconetto; Bianka Alzira Nascimento de Almeida; Paula Pierozan; Karin Dos Santos; Guilherme Razzera; Fátima Regina Mena Barreto Silva; Regina Pessoa-Pureur; Ariane Zamoner
Journal:  Mol Cell Endocrinol       Date:  2017-11-16       Impact factor: 4.102

9.  Differential Effects of 3,5-Diiodo-L-Thyronine and 3,5,3'-Triiodo-L-Thyronine On Mitochondrial Respiratory Pathways in Liver from Hypothyroid Rats.

Authors:  Elena Silvestri; Assunta Lombardi; Maria Coppola; Alessandra Gentile; Federica Cioffi; Rosalba Senese; Fernando Goglia; Antonia Lanni; Maria Moreno; Pieter de Lange
Journal:  Cell Physiol Biochem       Date:  2018-07-10

Review 10.  Similarities and Differences in the Peripheral Actions of Thyroid Hormones and Their Metabolites.

Authors:  Ruy A Louzada; Denise P Carvalho
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-19       Impact factor: 5.555

View more
  7 in total

Review 1.  Targeting Thyroid Hormone/Thyroid Hormone Receptor Axis: An Attractive Therapy Strategy in Liver Diseases.

Authors:  Qianyu Tang; Min Zeng; Linxi Chen; Nian Fu
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

2.  Potential Applications of Thyroid Hormone Derivatives in Obesity and Type 2 Diabetes: Focus on 3,5-Diiodothyronine (3,5-T2) in Psammomys obesus (Fat Sand Rat) Model.

Authors:  Asma Bouazza; Roland Favier; Eric Fontaine; Xavier Leverve; Elhadj-Ahmed Koceir
Journal:  Nutrients       Date:  2022-07-25       Impact factor: 6.706

3.  Changes in Thyroid Metabolites after Liothyronine Administration: A Secondary Analysis of Two Clinical Trials That Incorporated Pharmacokinetic Data.

Authors:  Nour Diab; Sameer Desale; Mark Danielsen; Josef Köhrle; Nawar Shara; Jacqueline Jonklaas
Journal:  Metabolites       Date:  2022-05-24

Review 4.  Thyroid hormone-dependent oligodendroglial cell lineage genomic and non-genomic signaling through integrin receptors.

Authors:  Rahimeh Emamnejad; Mary Dass; Michael Mahlis; Salome Bozkurt; Sining Ye; Maurice Pagnin; Paschalis Theotokis; Nikolaos Grigoriadis; Steven Petratos
Journal:  Front Pharmacol       Date:  2022-09-05       Impact factor: 5.988

Review 5.  Extranuclear effects of thyroid hormones and analogs during development: An old mechanism with emerging roles.

Authors:  Sandra Incerpi; Fabio Gionfra; Roberto De Luca; Elena Candelotti; Paolo De Vito; Zulema A Percario; Stefano Leone; Davide Gnocchi; Miriam Rossi; Francesco Caruso; Sergio Scapin; Paul J Davis; Hung-Yun Lin; Elisabetta Affabris; Jens Z Pedersen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-23       Impact factor: 6.055

Review 6.  Targeting Energy Expenditure-Drugs for Obesity Treatment.

Authors:  Carlos M Jimenez-Munoz; Marta López; Fernando Albericio; Kamil Makowski
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-06

Review 7.  Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders.

Authors:  Federica Saponaro; Simona Sestito; Massimiliano Runfola; Simona Rapposelli; Grazia Chiellini
Journal:  Front Med (Lausanne)       Date:  2020-07-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.